Citigroup lifted its price objective on Moderna, while CLSA raised Moderna to an outperform rating.

The entities involved

• Moderna →

  American biotechnology company

  • Biotech and pharmaceutical companies in Greater Boston are seeing strategic investments, talent movement, and antibody development advances.Tue 13:27
  • Moderna and BioNTech are recognized as leaders in the personalized cancer vaccine space.Sun 19:37
• Citigroup →

  American investment bank and financial services corporation

  • Citigroup upgraded Next plc to a buy rating, while Santander and Morgan Stanley also issued rating updates on the company.Tue 14:42
  • Citigroup restated a buy rating on SAP shares, and Morgan Stanley reiterated an overweight rating on the company.Tue 12:27
• CLSA →

  Capital markets and investment group

  • Talks between the US and China are underway, where the current US trade status is the key factor in establishing a conditional truce to avert a trade war.Mon 16:50
  • CLSA maintained an Outperform rating on Tata Communications on October 1, 2026.Fri 05:02

Related events

• Citigroup reissued a market outperform rating for Applied Digital Corporation on October 15, 2026.Fri 01:32
• Citigroup reaffirmed a market outperform rating for HealthEquity.Jul 29
• Citigroup reduced its price objective for Morgan Stanley stock on October 18, 2026.Sun 08:22
• Citigroup reaffirmed a market perform rating and Truist Financial cut its price target on stock on October 13, 2026.Oct 14
• Citigroup lifted its price target and gave a buy rating for Timken Company, with MarketBeat providing consensus data.Jul 2